EX-A5386

CAS No. 2452396-89-1

EX-A5386( —— )

Catalog No. M35951 CAS No. 2452396-89-1

EX-A5386 (Glucocorticoid receptor modulator-1) is a potent glucocorticoid receptor modulator, IC50/EC50<100nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 135 Get Quote
5MG 202 Get Quote
10MG 306 Get Quote
25MG 495 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EX-A5386
  • Note
    Research use only, not for human use.
  • Brief Description
    EX-A5386 (Glucocorticoid receptor modulator-1) is a potent glucocorticoid receptor modulator, IC50/EC50<100nM.
  • Description
    Glucocorticoid receptor modulator 2 (Example 1) is a glucocorticoid receptor modulator, with an IC50 value less than 100 nM. Glucocorticoid receptor modulator 2 can be used for research of inflammatory and immune diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Glucocorticoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2452396-89-1
  • Formula Weight
    482.55
  • Molecular Formula
    C29H27FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(=O)C1CC1)[C@@H]2[C@H](N(C(=O)C2(C)C)C=3C=C4C(=CC3)N(N=C4)C5=CC=C(F)C=C5)C6=CC=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Florian JAKOB, et al. Substituted pyrrolidine amides iii. Patent. WO2020144375.
molnova catalog
related products
  • Aristolone

    Aristolone has potential anti-cancer activity.

  • Mulberroside F

    Mulberroside F shows inhibitory effects on tyrosinase activity and on the melanin formation of melan-a cells, it also exhibits superoxide scavenging activity that is involved in the protection against auto-oxidation, suggests that mulberroside F may be used as a skin whitening agent.

  • WDR5-0102

    WDR5-0102 is a compound that inhibits the WDR5-MLL1 interface (K dis = 7 μM, K d = 4 μM), selectively reducing MLL1 HMT activity without affecting the human H3K4 methyltransferase SETD7 or other HMTs, including G9a, EHMT1, SUV39H2, SETD8, PRMT3, and PRMT5.